Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Massachusetts General Hospital
With
National Institutes of Health (NIH)
Bioenvision
Age
18–45
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Amenorrhea for at least three months (unless participating as healthy control)
Normal TSH or free thyroxine (free T4).
You may not be if
A condition known to affect bone metabolism, including Cushing's syndrome or renal failure, with the exception of bone fracture.
Any medication known to affect bone metabolism within 3 months of the study, including estrogen and progestins. Patients receiving depot medroxyprogesterone (Depo-Provera) will be excluded from participating for 6 months after their last injection.
